From www.merck.com: October 14, 2020 4:10 pm EDT KENILWORTH, N.J., Oct. 14, 2020 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it will construct a new manufacturing facility to significantly expand its production capacity for TICE® BCG (BCG Live For Intravesical Use), a medicine for the treatment ofRead more
Blog
Dear Bladder Cancer Canada friend, I know that you (or someone you care about) has been touched by bladder cancer. That’s not surprising, considering that 80,000 Canadians are currently living with bladder cancer and 12,000 more will be diagnosed this year. And while bladder cancer is the 5th most common cancer in Canada, it has a 60-70%Read more